Wells Fargo’s Sanofi SNY Stock Holding History

Wells Fargo’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,200	Closed	-$2K	–	6422
2015 Q2	$2K	Buy	+1,200	New	+$60.8K	﹤0.01%	6171
2014 Q4	–	Sell	-600	Closed	-$1K	–	6384
2014 Q3	$1K	Buy	+600	New	+$32.2K	﹤0.01%	6092

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Wells Fargo's SNY Position: Q2 2026 in Review

Wells Fargo reduced its Sanofi (SNY) stake by 4.1% in Q2 2026, selling an estimated $6.31M and leaving 3,273,820 shares worth $140M. The position accounts for 0.02% of the portfolio, ranked #547.

Wells Fargo first reported a position in SNY in Q2 2013 and has held it in 53 quarters since. The position peaked at $230M in Q2 2013. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Wells Fargo held 3,273,820 shares of Sanofi worth $140M as of Q2 2026.
Wells Fargo sold 141,295 Sanofi shares in Q2 2026, an estimated $6.31M.
Sanofi made up 0.02% of Wells Fargo's portfolio in Q2 2026, its #547 holding.
Wells Fargo first reported a position in Sanofi in Q2 2013 and has held it in 53 quarters since.
Wells Fargo's Sanofi position peaked at $230M in Q2 2013.
718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.